STEVEN A. SHALLCROSS

Profile

First Name

: STEVEN

Middle Name

: A.

Last Name

: SHALLCROSS

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

INNOCOLL HOLDINGS, INC.

COURTNEY CARSON, JAMES CULVERWELL, GORDON DUNN, KENNETH E. HIGGINS, DENNIS LANGER, MICHAEL MYERS, WILLIAM O-DONNELL, JOHN O-MEARA, PAUL G. OXHOLM, ROLF D. SCHMIDT, ANTHONY WILD

EXECUTIVE OFFICER, DIRECTOR

SYNTHETIC BIOLOGICS, INC.

C. EVAN BALLANTYNE, STEVE KANZER, STEVE H. KANZER, JEFFREY KRAWS, JEFFREY J. KRAWS, JOHN MONAHAN, JEFFREY RILEY, STEVEN SHALLCROSS, STEVEN A SHALLCROSS, JOSEPH SLIMAN, SCOTT TARRIFF, SCOTT L. TARRIFF, JEFFREY WOLF, JEFFREY A. WOLF

EXECUTIVE OFFICER, DIRECTOR

THERIVA BIOLOGICS, INC.

C. EVAN BALLANTYNE, STEVE KANZER, STEVE H. KANZER, JEFFREY KRAWS, JEFFREY J. KRAWS, JOHN MONAHAN, JEFFREY RILEY, STEVEN SHALLCROSS, STEVEN A SHALLCROSS, JOSEPH SLIMAN, SCOTT TARRIFF, SCOTT L. TARRIFF, JEFFREY WOLF, JEFFREY A. WOLF

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2025-10-17

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2022-07-29

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity, Debt

2010-08-13

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity, Debt

2010-05-13

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2009-12-21

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2009-04-22